|1.||Respiratory Tract Infections (Respiratory Tract Infection)
09/01/1993 - "The results show that erythromycin acistrate dosed twice daily is as effective as doxycycline and well tolerated in the treatment of lower respiratory tract infections."
09/01/1993 - "In the present double-blind trial, totally 297 ambulatory patients with respiratory tract infections were treated either with erythromycin acistrate 800 mg daily or doxycycline 100 mg daily. "
06/01/1988 - "Erythromycin acistrate and enterocoated pellets of erythromycin base in acute respiratory infections of hospitalized conscripts."
06/01/1988 - "Comparison of erythromycin acistrate and enterocoated erythromycin base in acute respiratory infections."
06/01/1988 - "Treatment of respiratory tract infections with erythromycin acistrate and two formulations of erythromycin base."
02/01/1991 - "Hepatic safety of erythromycin acistrate in 1549 patients with respiratory tract or skin infections."
09/01/1989 - "The efficacy of erythromycin stearate (ES) and its 2'-acetyl ester (erythromycin acistrate, EA) was compared in eight experimental infections in mice of both sexes. "
09/01/1989 - "Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice."
06/01/1988 - "Efficacy and tolerability of erythromycin acistrate and erythromycin stearate in acute skin infections of patients with atopic eczema."
11/01/1993 - "Efficacy and tolerance of erythromycin acistrate in the treatment of acute exacerbations of chronic bronchitis in the elderly."
11/01/1993 - "This randomized, investigator-blind, parallel-group trial compared erythromycin acistrate (EA) and erythromycin base (EB) in the treatment of elderly patients with acute exacerbations of chronic bronchitis. "
|4.||Erythromycin Ethylsuccinate (E-Mycin E)